Pfizer Inc. (ETR:PFE)

Germany flag Germany · Delayed Price · Currency is EUR
23.10
-0.20 (-0.86%)
Mar 28, 2025, 5:35 PM CET
-10.29%
Market Cap 131.40B
Revenue (ttm) 61.46B
Net Income (ttm) 7.76B
Shares Out n/a
EPS (ttm) 1.36
PE Ratio 16.94
Forward PE n/a
Dividend 1.58 (6.78%)
Ex-Dividend Date Jan 24, 2025
Volume 50,081
Average Volume 68,908
Open 23.24
Previous Close 23.30
Day's Range 22.97 - 23.27
52-Week Range 22.97 - 29.50
Beta 0.54
RSI 34.48
Earnings Date Apr 29, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr... [Read more]

Sector Healthcare
Founded 1849
Employees 81,000
Stock Exchange Deutsche Börse Xetra
Ticker Symbol PFE
Full Company Profile

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD Financial Statements

News

6 Ultra SWANs Potentially Set To Soar In 2025

The Dividend Kings Fortress Portfolio, composed exclusively of Ultra SWAN stocks (highest-quality blue chips), has delivered strong returns over the last six years. Just 20% of the holdings produced 7...

11 hours ago - Seeking Alpha

Pfizer: Value Play or Past Its Prime?

23 hours ago - The Motley Fool

Did Pfizer Delay Covid Vaccine Announcement Until After 2020 Election? Here's What We Know.

Federal investigators are investigating claims suggesting Pfizer delayed announcing test results of its Covid vaccine until after the 2020 presidential election, the Wall Street Journal reported, bols...

1 day ago - Forbes

Biotech stocks have been hit hard. Why they're a great value now.

Biotech is one of the U.S. stock market's most unloved sectors. But several indicators suggest that a bottom in sentiment could be near, and that's normally a good time to buy.

1 day ago - Market Watch

Feds probe tip that Pfizer delayed announcing COVID vaccine's success until after 2020 election: report

The report said GSK's former head of vaccine development, Philip Dormitzer, who joined the company after working at rival Pfizer, had told his GSK colleagues about the delay.

1 day ago - New York Post

Market Today: Pfizer Faces Investigation, Microsoft Scales Back Data Centers

Market Today: Pfizer Faces Investigation, Microsoft Scales Back Data Centers

2 days ago - GuruFocus

Pfizer Shares Are Down Today: What's Going On?

Pfizer Inc. (NYSE: PFE) shares are trading lower on Wednesday after a Wall Street Journal report revealed U.S. prosecutors are investigating a claim about the timing of Pfizer's COVID-19 vaccine anno...

2 days ago - Benzinga

US prosecutors probe tip about timing of Pfizer's COVID vaccine, WSJ reports

Federal prosecutors in Manhattan are probing a claim brought by GSK that Pfizer delayed announcing the success of its COVID-19 vaccine in 2020 until after that year's election, the Wall Street Journal...

2 days ago - Reuters

Pfizer Stock Slips After Report on Vaccine Timing Probe

2 days ago - The Wall Street Journal

U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine

Claim came to the U.S. attorney's office in Manhattan via Pfizer rival GSK.

2 days ago - WSJ

Pfizer Is Trading As If It's 2009 Again

3 days ago - Seeking Alpha

ForexLive Asia-Pacific FX news wrap: White House says scaling back April 2 tariff plan

Bank of England Governor Bailey speaks Monday, March 24, 2025: "Growth in the UK Economy" Barclays says further PBOC easing is becoming increasingly unavoidable The chair of UK investment bank Cavendi...

4 days ago - Forexlive

China Courts Apple, Pfizer, Eli Lilly Amid US Pressure, Vice Premier Says Beijing 'Will Continue To Improve The Business Environment'

On Sunday, Chinese Vice Premier He Lifeng met with top executives from Apple Inc. (NASDAQ: AAPL), Pfizer Inc. (NYSE: PFE), Mastercard Inc. (NYSE: MA), Eli Lilly and Co. (NYSE: LLY), Cargill , and ...

4 days ago - Benzinga

China vice premier He Lifeng met heads of Apple, Pfizer, MasterCard, Eli Lilly, Cargill

China vice premier he Lifeng met with heads of Apple, Pfizer, MasterCard, Eli Lilly, Cargill and others at business forum on Sunday – commerce ministry. This article was written by Eamonn Sheridan at ...

4 days ago - Forexlive

Pfizer: Bulls Need To Check Out Its Graham P/E

Pfizer's attractive dividend yield and low P/E ratio make it appealing. Learn why PFE stock's valuation risks may be higher due to bleak growth and debt levels.

6 days ago - Seeking Alpha

Alnylam Jumps As A New Approval Sets Up Its Next Battle With Pfizer, BridgeBio

Alnylam stock jumped Friday after the drugmaker won a second Food and Drug Administration approval for its drug, Amvuttra.

7 days ago - Investor's Business Daily

Buy 4 Ideal 'Safer' February Dividends, Out Of 40 Choices From Readers

Since May 2017, reader-selected dividend-paying stocks have been featured, with valuable reader feedback improving accuracy and direction. My Dogs of The Week portfolios are available for Dividend Dog...

8 days ago - Seeking Alpha

More Dividends, Less Drama: 3 Of My Favorite Dividend Stocks (5-7% Yield)

Uncertainty dominates the market, with consumer sentiment and business confidence at multi-year lows. Inflation fears persist, and policy support seems unlikely. Amid rising risks, I favor high-yield ...

8 days ago - Seeking Alpha

Vaccine success 'most profound moment of my life'

Pfizer scientist Dr Nicholas Kitchin shares the moment he heard the the Covid jab was a success.

8 days ago - BBC

Sensodyne toothpaste maker Haleon now an independent company after Pfizer sells stake

Shares in the consumer health group - originally a joint venture between Pfizer and GSK - are up nearly a fifth since it joined the stock market in 2022.

9 days ago - This is Money